世界の安定同位体標識化合物市場インサイト及び予測(水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他)

◆英語タイトル:Global Stable Isotopically Labeled Compounds Market Insights, Forecast to 2028

QYResearchが発行した調査報告書(QY22JLX02532)◆商品コード:QY22JLX02532
◆発行会社(リサーチ会社):QYResearch
◆発行日:2022年7月(※2025年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,117,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,489,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、安定同位体標識化合物のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に安定同位体標識化合物の世界市場のxxx%を占める「水-18O」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
安定同位体標識化合物の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの安定同位体標識化合物市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

安定同位体標識化合物のグローバル主要企業には、Rotem Industries Israel、Huayi Isotopes、ABX、CIL、Wosotop、Tayio Nippon Sanso、CMR、Cambridge Isotope Laboratories、Merck KGaA、Urenco Limited、Isosciences、Medical Isotopes、Omicron Biochemicals、BWX Technologies、Trace Sciences International、Alsachim、Perkinelmerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

安定同位体標識化合物市場は、種類と用途によって区分されます。世界の安定同位体標識化合物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他

【用途別セグメント】
科学研究、臨床診断、工業、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 安定同位体標識化合物製品概要
- 種類別市場(水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他)
- 用途別市場(科学研究、臨床診断、工業、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の安定同位体標識化合物販売量予測2017-2028
- 世界の安定同位体標識化合物売上予測2017-2028
- 安定同位体標識化合物の地域別販売量
- 安定同位体標識化合物の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別安定同位体標識化合物販売量
- 主要メーカー別安定同位体標識化合物売上
- 主要メーカー別安定同位体標識化合物価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他)
- 安定同位体標識化合物の種類別販売量
- 安定同位体標識化合物の種類別売上
- 安定同位体標識化合物の種類別価格
・用途別市場規模(科学研究、臨床診断、工業、その他)
- 安定同位体標識化合物の用途別販売量
- 安定同位体標識化合物の用途別売上
- 安定同位体標識化合物の用途別価格
・北米市場
- 北米の安定同位体標識化合物市場規模(種類別、用途別)
- 主要国別の安定同位体標識化合物市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの安定同位体標識化合物市場規模(種類別、用途別)
- 主要国別の安定同位体標識化合物市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の安定同位体標識化合物市場規模(種類別、用途別)
- 主要国別の安定同位体標識化合物市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の安定同位体標識化合物市場規模(種類別、用途別)
- 主要国別の安定同位体標識化合物市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの安定同位体標識化合物市場規模(種類別、用途別)
- 主要国別の安定同位体標識化合物市場規模(トルコ、サウジアラビア)
・企業情報
Rotem Industries Israel、Huayi Isotopes、ABX、CIL、Wosotop、Tayio Nippon Sanso、CMR、Cambridge Isotope Laboratories、Merck KGaA、Urenco Limited、Isosciences、Medical Isotopes、Omicron Biochemicals、BWX Technologies、Trace Sciences International、Alsachim、Perkinelmer
・産業チェーン及び販売チャネル分析
- 安定同位体標識化合物の産業チェーン分析
- 安定同位体標識化合物の原材料
- 安定同位体標識化合物の生産プロセス
- 安定同位体標識化合物の販売及びマーケティング
- 安定同位体標識化合物の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 安定同位体標識化合物の産業動向
- 安定同位体標識化合物のマーケットドライバー
- 安定同位体標識化合物の課題
- 安定同位体標識化合物の阻害要因
・主な調査結果

Market Analysis and Insights: Global Stable Isotopically Labeled Compounds Market
Due to the COVID-19 pandemic, the global Stable Isotopically Labeled Compounds market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Water-18O accounting for % of the Stable Isotopically Labeled Compounds global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Stable Isotopically Labeled Compounds market size is valued at US$ million in 2021, while the US and Europe Stable Isotopically Labeled Compounds are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Stable Isotopically Labeled Compounds landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Stable Isotopically Labeled Compounds include Rotem Industries Israel, Huayi Isotopes, ABX, CIL, Wosotop, Tayio Nippon Sanso, CMR, Cambridge Isotope Laboratories and Merck KGaA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Stable Isotopically Labeled Compounds capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Stable Isotopically Labeled Compounds by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Stable Isotopically Labeled Compounds Scope and Segment
Stable Isotopically Labeled Compounds market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Stable Isotopically Labeled Compounds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Water-18O
Oxygen-18O
13C Labelled Compounds
18F Labelled Compounds
11C Labelled Compounds
D Labelled Compounds
2H Labelled Compounds
15N Labelled Compounds
Others
Segment by Application
Scientific Research
Clinical Diagnostics
Industrial
Others
By Company
Rotem Industries Israel
Huayi Isotopes
ABX
CIL
Wosotop
Tayio Nippon Sanso
CMR
Cambridge Isotope Laboratories
Merck KGaA
Urenco Limited
Isosciences
Medical Isotopes
Omicron Biochemicals
BWX Technologies
Trace Sciences International
Alsachim
Perkinelmer
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Stable Isotopically Labeled Compounds Product Introduction
1.2 Market by Type
1.2.1 Global Stable Isotopically Labeled Compounds Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Water-18O
1.2.3 Oxygen-18O
1.2.4 13C Labelled Compounds
1.2.5 18F Labelled Compounds
1.2.6 11C Labelled Compounds
1.2.7 D Labelled Compounds
1.2.8 2H Labelled Compounds
1.2.9 15N Labelled Compounds
1.2.10 Others
1.3 Market by Application
1.3.1 Global Stable Isotopically Labeled Compounds Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Clinical Diagnostics
1.3.4 Industrial
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Stable Isotopically Labeled Compounds Production
2.1 Global Stable Isotopically Labeled Compounds Production Capacity (2017-2028)
2.2 Global Stable Isotopically Labeled Compounds Production by Region: 2017 VS 2021 VS 2028
2.3 Global Stable Isotopically Labeled Compounds Production by Region
2.3.1 Global Stable Isotopically Labeled Compounds Historic Production by Region (2017-2022)
2.3.2 Global Stable Isotopically Labeled Compounds Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Stable Isotopically Labeled Compounds Sales in Volume & Value Estimates and Forecasts
3.1 Global Stable Isotopically Labeled Compounds Sales Estimates and Forecasts 2017-2028
3.2 Global Stable Isotopically Labeled Compounds Revenue Estimates and Forecasts 2017-2028
3.3 Global Stable Isotopically Labeled Compounds Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Stable Isotopically Labeled Compounds Sales by Region
3.4.1 Global Stable Isotopically Labeled Compounds Sales by Region (2017-2022)
3.4.2 Global Sales Stable Isotopically Labeled Compounds by Region (2023-2028)
3.5 Global Stable Isotopically Labeled Compounds Revenue by Region
3.5.1 Global Stable Isotopically Labeled Compounds Revenue by Region (2017-2022)
3.5.2 Global Stable Isotopically Labeled Compounds Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Stable Isotopically Labeled Compounds Production Capacity by Manufacturers
4.2 Global Stable Isotopically Labeled Compounds Sales by Manufacturers
4.2.1 Global Stable Isotopically Labeled Compounds Sales by Manufacturers (2017-2022)
4.2.2 Global Stable Isotopically Labeled Compounds Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Stable Isotopically Labeled Compounds in 2021
4.3 Global Stable Isotopically Labeled Compounds Revenue by Manufacturers
4.3.1 Global Stable Isotopically Labeled Compounds Revenue by Manufacturers (2017-2022)
4.3.2 Global Stable Isotopically Labeled Compounds Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Stable Isotopically Labeled Compounds Revenue in 2021
4.4 Global Stable Isotopically Labeled Compounds Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Stable Isotopically Labeled Compounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Stable Isotopically Labeled Compounds Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Stable Isotopically Labeled Compounds Sales by Type
5.1.1 Global Stable Isotopically Labeled Compounds Historical Sales by Type (2017-2022)
5.1.2 Global Stable Isotopically Labeled Compounds Forecasted Sales by Type (2023-2028)
5.1.3 Global Stable Isotopically Labeled Compounds Sales Market Share by Type (2017-2028)
5.2 Global Stable Isotopically Labeled Compounds Revenue by Type
5.2.1 Global Stable Isotopically Labeled Compounds Historical Revenue by Type (2017-2022)
5.2.2 Global Stable Isotopically Labeled Compounds Forecasted Revenue by Type (2023-2028)
5.2.3 Global Stable Isotopically Labeled Compounds Revenue Market Share by Type (2017-2028)
5.3 Global Stable Isotopically Labeled Compounds Price by Type
5.3.1 Global Stable Isotopically Labeled Compounds Price by Type (2017-2022)
5.3.2 Global Stable Isotopically Labeled Compounds Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Stable Isotopically Labeled Compounds Sales by Application
6.1.1 Global Stable Isotopically Labeled Compounds Historical Sales by Application (2017-2022)
6.1.2 Global Stable Isotopically Labeled Compounds Forecasted Sales by Application (2023-2028)
6.1.3 Global Stable Isotopically Labeled Compounds Sales Market Share by Application (2017-2028)
6.2 Global Stable Isotopically Labeled Compounds Revenue by Application
6.2.1 Global Stable Isotopically Labeled Compounds Historical Revenue by Application (2017-2022)
6.2.2 Global Stable Isotopically Labeled Compounds Forecasted Revenue by Application (2023-2028)
6.2.3 Global Stable Isotopically Labeled Compounds Revenue Market Share by Application (2017-2028)
6.3 Global Stable Isotopically Labeled Compounds Price by Application
6.3.1 Global Stable Isotopically Labeled Compounds Price by Application (2017-2022)
6.3.2 Global Stable Isotopically Labeled Compounds Price Forecast by Application (2023-2028)
7 North America
7.1 North America Stable Isotopically Labeled Compounds Market Size by Type
7.1.1 North America Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
7.1.2 North America Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
7.2 North America Stable Isotopically Labeled Compounds Market Size by Application
7.2.1 North America Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
7.2.2 North America Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
7.3 North America Stable Isotopically Labeled Compounds Sales by Country
7.3.1 North America Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
7.3.2 North America Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Stable Isotopically Labeled Compounds Market Size by Type
8.1.1 Europe Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
8.1.2 Europe Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
8.2 Europe Stable Isotopically Labeled Compounds Market Size by Application
8.2.1 Europe Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
8.2.2 Europe Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
8.3 Europe Stable Isotopically Labeled Compounds Sales by Country
8.3.1 Europe Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
8.3.2 Europe Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Stable Isotopically Labeled Compounds Market Size by Type
9.1.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
9.1.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
9.2 Asia Pacific Stable Isotopically Labeled Compounds Market Size by Application
9.2.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
9.2.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
9.3 Asia Pacific Stable Isotopically Labeled Compounds Sales by Region
9.3.1 Asia Pacific Stable Isotopically Labeled Compounds Sales by Region (2017-2028)
9.3.2 Asia Pacific Stable Isotopically Labeled Compounds Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Stable Isotopically Labeled Compounds Market Size by Type
10.1.1 Latin America Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
10.1.2 Latin America Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
10.2 Latin America Stable Isotopically Labeled Compounds Market Size by Application
10.2.1 Latin America Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
10.2.2 Latin America Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
10.3 Latin America Stable Isotopically Labeled Compounds Sales by Country
10.3.1 Latin America Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
10.3.2 Latin America Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Stable Isotopically Labeled Compounds Market Size by Type
11.1.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Type (2017-2028)
11.1.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Type (2017-2028)
11.2 Middle East and Africa Stable Isotopically Labeled Compounds Market Size by Application
11.2.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Application (2017-2028)
11.2.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Application (2017-2028)
11.3 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country
11.3.1 Middle East and Africa Stable Isotopically Labeled Compounds Sales by Country (2017-2028)
11.3.2 Middle East and Africa Stable Isotopically Labeled Compounds Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Rotem Industries Israel
12.1.1 Rotem Industries Israel Corporation Information
12.1.2 Rotem Industries Israel Overview
12.1.3 Rotem Industries Israel Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Rotem Industries Israel Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Rotem Industries Israel Recent Developments
12.2 Huayi Isotopes
12.2.1 Huayi Isotopes Corporation Information
12.2.2 Huayi Isotopes Overview
12.2.3 Huayi Isotopes Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Huayi Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Huayi Isotopes Recent Developments
12.3 ABX
12.3.1 ABX Corporation Information
12.3.2 ABX Overview
12.3.3 ABX Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ABX Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ABX Recent Developments
12.4 CIL
12.4.1 CIL Corporation Information
12.4.2 CIL Overview
12.4.3 CIL Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 CIL Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 CIL Recent Developments
12.5 Wosotop
12.5.1 Wosotop Corporation Information
12.5.2 Wosotop Overview
12.5.3 Wosotop Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Wosotop Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Wosotop Recent Developments
12.6 Tayio Nippon Sanso
12.6.1 Tayio Nippon Sanso Corporation Information
12.6.2 Tayio Nippon Sanso Overview
12.6.3 Tayio Nippon Sanso Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Tayio Nippon Sanso Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Tayio Nippon Sanso Recent Developments
12.7 CMR
12.7.1 CMR Corporation Information
12.7.2 CMR Overview
12.7.3 CMR Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 CMR Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 CMR Recent Developments
12.8 Cambridge Isotope Laboratories
12.8.1 Cambridge Isotope Laboratories Corporation Information
12.8.2 Cambridge Isotope Laboratories Overview
12.8.3 Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Cambridge Isotope Laboratories Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Cambridge Isotope Laboratories Recent Developments
12.9 Merck KGaA
12.9.1 Merck KGaA Corporation Information
12.9.2 Merck KGaA Overview
12.9.3 Merck KGaA Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Merck KGaA Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Merck KGaA Recent Developments
12.10 Urenco Limited
12.10.1 Urenco Limited Corporation Information
12.10.2 Urenco Limited Overview
12.10.3 Urenco Limited Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Urenco Limited Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Urenco Limited Recent Developments
12.11 Isosciences
12.11.1 Isosciences Corporation Information
12.11.2 Isosciences Overview
12.11.3 Isosciences Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Isosciences Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Isosciences Recent Developments
12.12 Medical Isotopes
12.12.1 Medical Isotopes Corporation Information
12.12.2 Medical Isotopes Overview
12.12.3 Medical Isotopes Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Medical Isotopes Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Medical Isotopes Recent Developments
12.13 Omicron Biochemicals
12.13.1 Omicron Biochemicals Corporation Information
12.13.2 Omicron Biochemicals Overview
12.13.3 Omicron Biochemicals Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Omicron Biochemicals Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Omicron Biochemicals Recent Developments
12.14 BWX Technologies
12.14.1 BWX Technologies Corporation Information
12.14.2 BWX Technologies Overview
12.14.3 BWX Technologies Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 BWX Technologies Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 BWX Technologies Recent Developments
12.15 Trace Sciences International
12.15.1 Trace Sciences International Corporation Information
12.15.2 Trace Sciences International Overview
12.15.3 Trace Sciences International Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Trace Sciences International Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Trace Sciences International Recent Developments
12.16 Alsachim
12.16.1 Alsachim Corporation Information
12.16.2 Alsachim Overview
12.16.3 Alsachim Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Alsachim Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Alsachim Recent Developments
12.17 Perkinelmer
12.17.1 Perkinelmer Corporation Information
12.17.2 Perkinelmer Overview
12.17.3 Perkinelmer Stable Isotopically Labeled Compounds Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 Perkinelmer Stable Isotopically Labeled Compounds Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 Perkinelmer Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Stable Isotopically Labeled Compounds Industry Chain Analysis
13.2 Stable Isotopically Labeled Compounds Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Stable Isotopically Labeled Compounds Production Mode & Process
13.4 Stable Isotopically Labeled Compounds Sales and Marketing
13.4.1 Stable Isotopically Labeled Compounds Sales Channels
13.4.2 Stable Isotopically Labeled Compounds Distributors
13.5 Stable Isotopically Labeled Compounds Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Stable Isotopically Labeled Compounds Industry Trends
14.2 Stable Isotopically Labeled Compounds Market Drivers
14.3 Stable Isotopically Labeled Compounds Market Challenges
14.4 Stable Isotopically Labeled Compounds Market Restraints
15 Key Finding in The Global Stable Isotopically Labeled Compounds Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の安定同位体標識化合物市場インサイト及び予測(水-18O、酸素-18O、13C標識化合物、18F標識化合物、11C標識化合物、D標識化合物、2H標識化合物、15N標識化合物、その他)(Global Stable Isotopically Labeled Compounds Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。